Addressing issues in clinical development of AAV-driven gene therapy

Published: 14 July 2021
Sabah Sallah

Sabah Sallah, MD, PhD, current position: Senior Vice President of Gene Therapy, Translational Medicine and Hematology at Freeline Therapeutics, Boston, MA, USA. He is board certified in Internal Medicine, Hematology and Oncology and has published approximately 100 peer-reviewed papers, chapters and books.

Read now